Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Chlamydia/gonorrhea tests draft guidance
You may also be interested in...
Regulatory News In Brief
ReGen sues FDA
Regulatory News In Brief
ReGen sues FDA
Combination Products Office Finalizing Manufacturing, Adverse Event Rules
FDA says final rules on good manufacturing practices and adverse event reporting for combination products could be out as early as this fall.